Anyone have ballpark numbers on the expected AI compute capacity, power draw, and projected revenue from these new data centers? How does TSLA’s TCO compare to MSFT or AMZN, and what’s the expected ROI timeline?
Interesting pivot into hyperscale, but data center margins are tight; I’m cautiously optimistic if they can keep OpEx under control.
Feels like marketing hype; execution risk is real.
https://t.co/ahJpUyBz5K
https://t.co/CeNL99bgO1ORCL--
https://t.co/H8wFT5mEBlSPCX--
NVDA dominance is impressive, but margins and demand could slip. I’m not convinced this is a durable moat versus AMD or others.
NVDA pop looks overdone; I’m fading strength into resistance. BRK.A trim could spark a bounce, but I’ll fade that too.
Feels like a classic Berkshire pivot: trim NVDA after the run, add more room for error. I’m nibbling on cash and watching for dips.
https://t.co/nlFQ58x3gRNVDA--
Feels like a classic squeeze: board blocks Jensen’s return, stock pops, then fades. I’m uneasy trusting headlines over fundamentals.
I’m new here and kinda confused. If the board says no to Jensen’s return, why is NVDA going up? Does that mean investors are still bullish, or is it just a reaction?
Watching NVDA from the sidelines; the board move feels messy, but the sector momentum is real. Might nibble if it cools.
https://t.co/4f2TEcvsjs
Feels like the market’s already pricing in multiple expansion; I’d expect a pullback before real earnings momentum kicks in.
So this vaccine got FDA approval and stock jumped 170%?
I’m torn here. The headline is exciting, but I’m uneasy about how fast this popped. If it’s just a one-off catalyst, sentiment could fade fast. I’d rather see consistent data and durable demand before getting emotional.
